Health Catalyst, Inc.
HCAT
$3.38
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 316.09M | 311.27M | 306.58M | 302.06M | 299.48M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 316.09M | 311.27M | 306.58M | 302.06M | 299.48M |
| Cost of Revenue | 170.69M | 168.28M | 164.79M | 162.59M | 162.10M |
| Gross Profit | 145.41M | 143.00M | 141.79M | 139.47M | 137.38M |
| SG&A Expenses | 98.18M | 96.54M | 100.65M | 103.32M | 107.80M |
| Depreciation & Amortization | 45.25M | 43.23M | 41.43M | 41.47M | 41.68M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 368.35M | 363.97M | 363.68M | 366.31M | 373.96M |
| Operating Income | -52.26M | -52.69M | -57.10M | -64.25M | -74.48M |
| Income Before Tax | -99.67M | -72.22M | -69.17M | -79.29M | -86.06M |
| Income Tax Expenses | 446.00K | 435.00K | 333.00K | -149.00K | 385.00K |
| Earnings from Continuing Operations | -100.12 | -72.66 | -69.50 | -79.14 | -86.45 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -100.12M | -72.66M | -69.50M | -79.14M | -86.45M |
| EBIT | -52.26M | -52.69M | -57.10M | -64.25M | -74.48M |
| EBITDA | -17.90M | -19.67M | -25.37M | -32.08M | -41.70M |
| EPS Basic | -1.51 | -1.15 | -1.15 | -1.35 | -1.50 |
| Normalized Basic EPS | -0.61 | -0.57 | -0.59 | -0.62 | -0.70 |
| EPS Diluted | -1.51 | -1.15 | -1.15 | -1.35 | -1.50 |
| Normalized Diluted EPS | -0.61 | -0.57 | -0.59 | -0.62 | -0.70 |
| Average Basic Shares Outstanding | 261.00M | 250.67M | 240.71M | 235.81M | 232.08M |
| Average Diluted Shares Outstanding | 261.00M | 250.67M | 240.71M | 235.81M | 232.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |